{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:34:36Z","timestamp":1786728876479,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA057645"],"award-info":[{"award-number":["R01 DA057645"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Syringe services programs (SSPs) reduce the risk of overdose by distributing supplies like naloxone. SSPs also support clients in meeting their basic needs via referrals to organizations providing food, housing, and healthcare. This paper describes the Exploration of Novel Harm Reduction Approaches to Increase Client Engagement (ENHANCE) Project, a prospective cohort study developed in partnership with people who use drugs that aims to characterize the influence of longitudinal engagement in SSPs on overdose risk behaviors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The ENHANCE Project protocol was developed with a community leadership team of 16 people with living experience of drug use who were clients from four SSPs in Wisconsin that serve as study recruitment sites. The community leadership team met five times to conceptualize the study priorities, protocol, recruitment strategies, and measures. ENHANCE will enroll 400 people who use opioids and\/or stimulants via recruitment of clients from study sites and peer referrals. Clients will report on primary outcomes (overdose experiences and risk behaviors) and other covariates (substance use history and behaviors, mental and physical health, satisfaction of basic needs, stigma, and others) over a 2-year follow-up period. At enrollment, clients select a self-generated identification code that is documented in all subsequent harm reduction services received from ten SSPs in Wisconsin. These data will be linked to study survey data using probabilistic methods and used for the primary exposure variable, frequency of using SSP services. ENHANCE will test the primary hypothesis that more frequently using SSP services is associated with reduced overdose risk behavior frequency.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>Preliminary results:<\/jats:bold>\n                    <\/jats:p>\n                    <jats:p>\n                      Among the first 125 clients enrolled, 22.4% (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200928) reported personally experiencing an opioid overdose in the 6\u00a0months before enrollment and 38.4% (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200948) experienced adverse effects after using stimulants. The most common overdose risk behaviors reported in the past 30\u00a0days were using opioids while alone (mean: 9.9\u00a0days [standard deviation: 10.7]) and injecting heroin (mean: 9.3\u00a0days [standard deviation: 12.8]).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study will identify aspects of harm reduction services that are most effective in reducing overdose risk to inform future service provision, funding, and policy efforts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12954-025-01212-0","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T02:51:50Z","timestamp":1747623110000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploration of novel harm reduction approaches to increase client engagement (ENHANCE): protocol for a prospective cohort study"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7022-6385","authenticated-orcid":false,"given":"Rachel E.","family":"Gicquelais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin J.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikaela","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika J.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cullen","family":"Bosworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Mijal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmie","family":"Curran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Barredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Salisbury-Afshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Seal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marguerite","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"Westergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"1212_CR1","unstructured":"Ahmad F, Cisewski J, Rossen L, Sutton P. Provisional drug overdose death counts. [Internet]. 2024 [cited 2024 Mar 29]. Available from: https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm"},{"key":"1212_CR2","unstructured":"United Nations Office on Drugs and Crime. COVID-19 and the drug supply chain: from production and trafficking to use [Internet]. 2020. Available from: http:\/\/www.unodc.org\/documents\/data-and-analysis\/covid\/Covid-19-and-drug-supply-chain-Mai2020.pdf"},{"key":"1212_CR3","doi-asserted-by":"crossref","unstructured":"Mattson CL. Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths\u2014United States, 2013\u20132019. MMWR Morb Mortal Wkly Rep [Internet]. 2021 [cited 2024 Mar 29]; 70. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/70\/wr\/mm7006a4.htm","DOI":"10.15585\/mmwr.mm7006a4"},{"key":"1212_CR4","doi-asserted-by":"crossref","unstructured":"Tsai AC, Kiang MV, Barnett ML, Beletsky L, Keyes KM, McGinty EE, et al. Stigma as a fundamental hindrance to the United States opioid overdose crisis response. PLoS Med [Internet]. 2019 [cited 2021 May 23];16. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6957118\/","DOI":"10.1371\/journal.pmed.1002969"},{"key":"1212_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.3821","volume":"5","author":"PM Mauro","year":"2022","unstructured":"Mauro PM, Gutkind S, Annunziato EM, Samples H. Use of medication for opioid use disorder among US adolescents and adults with need for opioid treatment, 2019. JAMA Netw Open. 2022;5: e223821.","journal-title":"JAMA Netw Open"},{"key":"1212_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.7326\/M20-1491","volume":"173","author":"S Woolhandler","year":"2020","unstructured":"Woolhandler S, Himmelstein DU. Intersecting US epidemics: COVID-19 and lack of health insurance. Ann Intern Med. 2020;173:63\u20134.","journal-title":"Ann Intern Med"},{"key":"1212_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.15585\/mmwr.mm7005a3","volume":"70","author":"LR McKnight-Eily","year":"2021","unstructured":"McKnight-Eily LR, Okoro CA, Strine TW, Verlenden J, Hollis ND, Njai R, et al. Racial and ethnic disparities in the prevalence of stress and worry, mental health conditions, and increased substance use among adults during the COVID-19 pandemic - United States, April and May 2020. MMWR Morb Mortal Wkly Rep. 2021;70:162\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1212_CR8","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.15585\/mmwr.mm6932a1","volume":"69","author":"M\u00c9 Czeisler","year":"2020","unstructured":"Czeisler M\u00c9, Lane RI, Petrosky E, Wiley JF, Christensen A, Njai R, et al. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic - United States, June 24\u201330, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1049\u201357.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1212_CR9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.drugpo.2013.03.005","volume":"24","author":"M Mofizul Islam","year":"2013","unstructured":"Mofizul Islam M, Topp L, Conigrave KM, Day CA. Defining a service for people who use drugs as \u2018low-threshold\u2019: what should be the criteria? Int J Drug Policy. 2013;24:220\u20132.","journal-title":"Int J Drug Policy"},{"key":"1212_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0740-5472(00)00104-5","volume":"19","author":"H Hagan","year":"2000","unstructured":"Hagan H, McGough JP, Thiede H, Hopkins S, Duchin J, Alexander ER. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. J Subst Abuse Treat. 2000;19:247\u201352.","journal-title":"J Subst Abuse Treat"},{"key":"1212_CR11","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.15585\/mmwr.mm6448a3","volume":"64","author":"DC Des Jarlais","year":"2015","unstructured":"Des Jarlais DC, Nugent A, Solberg A, Feelemyer J, Mermin J, Holtzman D. Syringe service programs for persons who inject drugs in urban, suburban, and rural areas\u2013United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64:1337\u201341.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1212_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12889-017-4210-2","volume":"17","author":"RM Fernandes","year":"2017","unstructured":"Fernandes RM, Cary M, Duarte G, Jesus G, Alarc\u00e3o J, Torre C, et al. Effectiveness of needle and syringe Programmes in people who inject drugs\u2013An overview of systematic reviews. BMC Public Health. 2017;17:309.","journal-title":"BMC Public Health"},{"key":"1212_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012021.pub2","author":"L Platt","year":"2017","unstructured":"Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, Jordan A, Degenhardt L, Hope V, Hutchinson S, Maher L, Palmateer N, Taylor A, Bruneau J, Hickman M. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs. Cochrane Database Syst Rev. 2017. https:\/\/doi.org\/10.1002\/14651858.CD012021.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"1212_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12954-021-00565-6","volume":"18","author":"PL Marotta","year":"2021","unstructured":"Marotta PL, Stringer K, Beletsky L, West BS, Goddard-Eckrich D, Gilbert L, et al. Assessing the relationship between syringe exchange, pharmacy, and street sources of accessing syringes and injection drug use behavior in a pooled nationally representative sample of people who inject drugs in the United States from 2002 to 2019. Harm Reduct J. 2021;18:115.","journal-title":"Harm Reduct J"},{"key":"1212_CR15","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.2105\/AJPH.2009.184580","volume":"101","author":"HLF Cooper","year":"2011","unstructured":"Cooper HLF, Des Jarlais DC, Ross Z, Tempalski B, Bossak B, Friedman SR. Spatial access to syringe exchange programs and pharmacies selling over-the-counter syringes as predictors of drug injectors\u2019 use of sterile syringes. Am J Public Health. 2011;101:1118\u201325.","journal-title":"Am J Public Health"},{"key":"1212_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.drugpo.2019.07.010","volume":"73","author":"M Reed","year":"2019","unstructured":"Reed M, Wagner KD, Tran NK, Brady KA, Shinefeld J, Roth A. Prevalence and correlates of carrying naloxone among a community-based sample of opioid-using people who inject drugs. Int J Drug Policy. 2019;73:32\u20135.","journal-title":"Int J Drug Policy"},{"key":"1212_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12954-020-00376-1","volume":"17","author":"KJ Bornstein","year":"2020","unstructured":"Bornstein KJ, Coye AE, St. Onge JE, Li H, Muller A, Bartholomew TS, et al. Hospital admissions among people who inject opioids following syringe services program implementation. Harm Reduct J. 2020;17:30.","journal-title":"Harm Reduct J"},{"key":"1212_CR18","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S0140-6736(10)62353-7","volume":"377","author":"BDL Marshall","year":"2011","unstructured":"Marshall BDL, Milloy M-J, Wood E, Montaner JSG, Kerr T. Reduction in overdose mortality after the opening of North America\u2019s first medically supervised safer injecting facility: a retrospective population-based study. Lancet. 2011;377:1429\u201337.","journal-title":"Lancet"},{"key":"1212_CR19","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1016\/S2468-2667(21)00304-2","volume":"7","author":"MA Irvine","year":"2022","unstructured":"Irvine MA, Oller D, Boggis J, Bishop B, Coombs D, Wheeler E, et al. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study. Lancet Public Health. 2022;7:e210\u20138.","journal-title":"Lancet Public Health"},{"key":"1212_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/jrh.12698","volume":"39","author":"DM Carpenter","year":"2023","unstructured":"Carpenter DM, Zule WA, Hennessy CM, Evon DM, Hurt CB, Ostrach B. Factors associated with perceived ease of access to syringes in Appalachian North Carolina. J Rural Health. 2023;39:212\u201322.","journal-title":"J Rural Health"},{"key":"1212_CR21","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1007\/s10461-021-03247-3","volume":"25","author":"ST Allen","year":"2021","unstructured":"Allen ST, White RH, O\u2019Rourke A, Schneider KE, Weir BW, Lucas GM, et al. Syringe coverage among people who inject drugs in West Virginia, USA. AIDS Behav. 2021;25:3377\u201385.","journal-title":"AIDS Behav"},{"key":"1212_CR22","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/jvh.13735","volume":"29","author":"MA Barranco","year":"2022","unstructured":"Barranco MA, Rosenberg ES, Flanigan C, Shufelt S, Bruce EM, Wilberschied LA, et al. A cross-sectional study of hepatitis C prevalence and correlates among persons who inject drugs in rural and non-rural communities. J Viral Hepat. 2022;29:994\u20131003.","journal-title":"J Viral Hepat"},{"key":"1212_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12954-020-00452-6","volume":"17","author":"A Davitadze","year":"2020","unstructured":"Davitadze A, Meylakhs P, Lakhov A, King EJ. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work. Harm Reduct J. 2020;17:98.","journal-title":"Harm Reduct J"},{"issue":"4","key":"1212_CR24","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3109\/09638237.2012.682265","volume":"21","author":"Z Davey","year":"2012","unstructured":"Davey Z, Schifano F, Corazza O, Deluca P. e-Psychonauts: conducting research in online drug forum communities. J Mental Health. 2012;21(4):386\u201394. https:\/\/doi.org\/10.3109\/09638237.2012.682265.","journal-title":"J Mental Health"},{"key":"1212_CR25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1108\/DAT-10-2018-0052","volume":"19","author":"S Rolando","year":"2019","unstructured":"Rolando S, Beccaria F. \u201cThe junkie abuses, the psychonaut learns\u201d: a qualitative analysis of an online drug forum community. Drugs Alcohol Today. 2019;19:282\u201394.","journal-title":"Drugs Alcohol Today"},{"key":"1212_CR26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.drugpo.2018.05.008","volume":"58","author":"K Masson","year":"2018","unstructured":"Masson K, Bancroft A. \u201cNice people doing shady things\u201d: drugs and the morality of exchange in the darknet cryptomarkets. Int J Drug Policy. 2018;58:78\u201384.","journal-title":"Int J Drug Policy"},{"key":"1212_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12954-020-00403-1","volume":"17","author":"M Torres-Leguizamon","year":"2020","unstructured":"Torres-Leguizamon M, Reynaud EG, N\u00e9fau T, Duplessy C. HaRePo (harm reduction by post): an innovative and effective harm reduction programme for people who use drugs using email, telephone, and post service. Harm Reduct J. 2020;17:59.","journal-title":"Harm Reduct J"},{"key":"1212_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/14659891.2022.2144500","volume":"29","author":"BT Hayes","year":"2024","unstructured":"Hayes BT, Favaro J, Behrends CN, Coello D, Jakubowski A, Fox AD. NEXT: description, rationale, and evaluation of a novel internet-based mail-delivered syringe service program. J Subst Use. 2024;29:129\u201335.","journal-title":"J Subst Use"},{"key":"1212_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104121","volume":"119","author":"W Rioux","year":"2023","unstructured":"Rioux W, Marshall T, Ghosh SM. Virtual overdose monitoring services and overdose prevention technologies: opportunities, limitations, and future directions. Int J Drug Policy. 2023;119: 104121.","journal-title":"Int J Drug Policy"},{"key":"1212_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12954-023-00765-2","volume":"20","author":"E Russell","year":"2023","unstructured":"Russell E, Johnson J, Kosinski Z, Kaplan C, Barnes N, Allen S, et al. A scoping review of implementation considerations for harm reduction vending machines. Harm Reduct J. 2023;20:33.","journal-title":"Harm Reduct J"},{"key":"1212_CR31","doi-asserted-by":"publisher","DOI":"10.2196\/25428","volume":"23","author":"T Shelby","year":"2021","unstructured":"Shelby T, Zhou X, Barber D, Altice F. Acceptability of an mHealth app that provides harm reduction services among people who inject drugs: survey study. J Med Internet Res. 2021;23: e25428.","journal-title":"J Med Internet Res"},{"key":"1212_CR32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12954-023-00807-9","volume":"20","author":"T Marshall","year":"2023","unstructured":"Marshall T, Viste D, Jones S, Kim J, Lee A, Jafri F, et al. Beliefs, attitudes and experiences of virtual overdose monitoring services from the perspectives of people who use substances in Canada: a qualitative study. Harm Reduct J. 2023;20:80.","journal-title":"Harm Reduct J"},{"key":"1212_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12954-023-00747-4","volume":"20","author":"RE Stewart","year":"2023","unstructured":"Stewart RE, Cardamone NC, Loscalzo E, French R, Lovelace C, Mowenn WK, et al. \u201cThere\u2019s absolutely no downside to this, I mean, except community opposition:\u201d a qualitative study of the acceptability of vending machines for harm reduction. Harm Reduct J. 2023;20:25.","journal-title":"Harm Reduct J"},{"key":"1212_CR34","unstructured":"National Harm Reduction Coalition. Principles of Harm Reduction [Internet]. [cited 2024 Mar 29]. Available from: https:\/\/harmreduction.org\/about-us\/principles-of-harm-reduction\/"},{"key":"1212_CR35","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s10461-020-03141-4","volume":"25","author":"A Seaman","year":"2021","unstructured":"Seaman A, Leichtling G, Stack E, Gray M, Pope J, Larsen JE, et al. Harm reduction and adaptations among PWUD in rural oregon during COVID-19. AIDS Behav. 2021;25:1331\u20139.","journal-title":"AIDS Behav"},{"key":"1212_CR36","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1177\/1049732311403500","volume":"21","author":"MJ Montoya","year":"2011","unstructured":"Montoya MJ, Kent EE. Dialogical action: moving from community-based to community-driven participatory research. Qual Health Res. 2011;21:1000\u201311.","journal-title":"Qual Health Res"},{"key":"1212_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103364","volume":"98","author":"C Simon","year":"2021","unstructured":"Simon C, Brothers S, Strichartz K, Coulter A, Voyles N, Herdlein A, et al. We are the researched, the researchers, and the discounted: the experiences of drug user activists as researchers. Int J Drug Policy. 2021;98: 103364.","journal-title":"Int J Drug Policy"},{"key":"1212_CR38","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/08897077.2017.1282914","volume":"38","author":"ER Pouget","year":"2017","unstructured":"Pouget ER, Bennett AS, Elliott L, Wolfson-Stofko B, Alme\u00f1ana R, Britton PC, et al. Development of an opioid-related overdose risk behavior scale (ORBS). Subst Abus. 2017;38:239\u201344.","journal-title":"Subst Abus"},{"key":"1212_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108721","volume":"223","author":"L Elliott","year":"2021","unstructured":"Elliott L, Crasta D, Khan M, Roth A, Green T, Kolodny A, et al. Validation of the opioid overdose risk behavior scale, version 2 (ORBS-2). Drug Alcohol Depend. 2021;223: 108721.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"1212_CR40","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","volume":"34","author":"D Ciccarone","year":"2021","unstructured":"Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Current Opinion Psychiatry. 2021;34(4):344\u201350. https:\/\/doi.org\/10.1097\/YCO.0000000000000717.","journal-title":"Current Opinion Psychiatry"},{"issue":"2","key":"1212_CR41","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1176\/appi.ajp.2021.21040381","volume":"179","author":"J Friedman","year":"2022","unstructured":"Friedman J, Beletsky L, Jordan A. Surging racial disparities in the US overdose crisis. American J Psychiatry. 2022;179(2):166\u20139. https:\/\/doi.org\/10.1176\/appi.ajp.2021.21040381.","journal-title":"American J Psychiatry"},{"issue":"17","key":"1212_CR42","doi-asserted-by":"publisher","first-page":"388","DOI":"10.15585\/mmwr.mm6817a3","volume":"68","author":"M Kariisa","year":"2019","unstructured":"Kariisa M, Scholl L, Wilson N, Seth P, Hoots B. Drug Overdose deaths involving cocaine and psychostimulants with abuse potential\u2014United States, 2003\u20132017. MMWR Morbidity Mortality Weekly Rep. 2019;68(17):388\u201395. https:\/\/doi.org\/10.15585\/mmwr.mm6817a3.","journal-title":"MMWR. Morbidity Mortality Weekly Rep"},{"key":"1212_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109001","volume":"227","author":"M Kariisa","year":"2021","unstructured":"Kariisa M, Seth P, Scholl L, Wilson N, Davis NL. Drug overdose deaths involving cocaine and psychostimulants with abuse potential among racial and ethnic groups - United States, 2004\u20132019. Drug Alcohol Depend. 2021;227: 109001.","journal-title":"Drug Alcohol Depend"},{"key":"1212_CR44","unstructured":"Supporting Harm Reduction Programs (SHaRP), Deutsch S, Palayew A, Price BN, McKnight C, Des Jarlais D, et al. Using Unique Identifiers Within Syringe Services Programs [Internet]. University of Washington; 2022. Available from: https:\/\/www.sharpta.uw.edu\/syringe-services-program-monitoring-and-evaluation-resources\/using-unique-identifiers-within-syringe-services-programs\/"},{"key":"1212_CR45","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s11031-014-9450-1","volume":"39","author":"B Chen","year":"2015","unstructured":"Chen B, Vansteenkiste M, Beyers W, Boone L, Deci EL, Van der Kaap-Deeder J, et al. Basic psychological need satisfaction, need frustration, and need strength across four cultures. Motiv Emot. 2015;39:216\u201336.","journal-title":"Motiv Emot"},{"key":"1212_CR46","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugalcdep.2016.02.019","volume":"162","author":"LR Smith","year":"2016","unstructured":"Smith LR, Earnshaw VA, Copenhaver MM, Cunningham CO. Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations. Drug Alcohol Depend. 2016;162:34\u201343.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"1212_CR47","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1177\/00220426231168081","volume":"54","author":"L Elliott","year":"2024","unstructured":"Elliott L, Chen Y, Goodman M, Bennett AS. Distal factors associated with proximal overdose risk behaviors and recent non-fatal overdose among a sample of people who use illicit opioids in New York City. J Drug Issues. 2024;54(3):457\u201375.","journal-title":"J Drug Issues"},{"key":"1212_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-016-0114-1","author":"D Werb","year":"2016","unstructured":"Werb D, Garfein R, Kerr T, Davidson P, Roux P, Jauffret-Roustide M, Auriacombe M, Small W, Strathdee SA. A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study. Harm Reduct J. 2016. https:\/\/doi.org\/10.1186\/s12954-016-0114-1.","journal-title":"Harm Reduct J"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01212-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01212-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01212-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:43:08Z","timestamp":1786725788000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-025-01212-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":48,"journal-issue":{"issue":"S1","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["1212"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01212-0","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"17 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was reviewed and approved by the Health Sciences Institutional Review Board at the University of Wisconsin-Madison (Study ID: 2023\u20131069). All clients provided informed consent before participating in the ENHANCE Project.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"81"}}